

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.14301901 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.14301901 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.10484164 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.10484164 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.69148796 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.40224681 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.40224681 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.40224681 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.37805373 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.33714001 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.33619099 |
| 12 | lysine metabolic process (GO:0006553) | 4.98740867 |
| 13 | lysine catabolic process (GO:0006554) | 4.98740867 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.97183376 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.93565082 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.74016487 |
| 17 | oxaloacetate metabolic process (GO:0006107) | 4.72992947 |
| 18 | cysteine metabolic process (GO:0006534) | 4.64513486 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 4.61082428 |
| 20 | urea cycle (GO:0000050) | 4.59513315 |
| 21 | urea metabolic process (GO:0019627) | 4.59513315 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.58429906 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.53899115 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.50141092 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.48123965 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.30200678 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.29477557 |
| 28 | exogenous drug catabolic process (GO:0042738) | 4.29117591 |
| 29 | 2-oxoglutarate metabolic process (GO:0006103) | 4.28931484 |
| 30 | alpha-amino acid catabolic process (GO:1901606) | 4.26306193 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.21514274 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.16571252 |
| 33 | glycine metabolic process (GO:0006544) | 4.15582107 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13627482 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.12786300 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.12680702 |
| 37 | bile acid metabolic process (GO:0008206) | 4.11353443 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.06893468 |
| 39 | coenzyme catabolic process (GO:0009109) | 4.04384712 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.04054887 |
| 41 | imidazole-containing compound metabolic process (GO:0052803) | 4.01171266 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 3.98884488 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 3.98884488 |
| 44 | macromolecular complex remodeling (GO:0034367) | 3.98884488 |
| 45 | reverse cholesterol transport (GO:0043691) | 3.97325981 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 3.94747957 |
| 47 | regulation of plasminogen activation (GO:0010755) | 3.92309889 |
| 48 | vitamin catabolic process (GO:0009111) | 3.90643204 |
| 49 | fat-soluble vitamin catabolic process (GO:0042363) | 3.90643204 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.87310019 |
| 51 | NAD metabolic process (GO:0019674) | 3.86556254 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.82909124 |
| 53 | protein carboxylation (GO:0018214) | 3.82909124 |
| 54 | NADH metabolic process (GO:0006734) | 3.79318455 |
| 55 | aldehyde catabolic process (GO:0046185) | 3.78595030 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 3.76062150 |
| 57 | regulation of complement activation (GO:0030449) | 3.75850387 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.75517525 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.75453578 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.75453578 |
| 61 | aspartate family amino acid catabolic process (GO:0009068) | 3.74908149 |
| 62 | phenylpropanoid metabolic process (GO:0009698) | 3.74721685 |
| 63 | NAD biosynthetic process (GO:0009435) | 3.74181786 |
| 64 | glutamate metabolic process (GO:0006536) | 3.70719787 |
| 65 | phospholipid efflux (GO:0033700) | 3.69436314 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.68941927 |
| 67 | alkaloid metabolic process (GO:0009820) | 3.67710607 |
| 68 | amine catabolic process (GO:0009310) | 3.67022021 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.67022021 |
| 70 | tolerance induction (GO:0002507) | 3.66741704 |
| 71 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.64325887 |
| 72 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.64325887 |
| 73 | ethanol oxidation (GO:0006069) | 3.60938693 |
| 74 | arginine metabolic process (GO:0006525) | 3.60711554 |
| 75 | cofactor catabolic process (GO:0051187) | 3.58598481 |
| 76 | negative regulation of sterol transport (GO:0032372) | 3.58457036 |
| 77 | negative regulation of cholesterol transport (GO:0032375) | 3.58457036 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.58236975 |
| 79 | organic acid catabolic process (GO:0016054) | 3.57588306 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.57588306 |
| 81 | short-chain fatty acid metabolic process (GO:0046459) | 3.57378236 |
| 82 | carnitine metabolic process (GO:0009437) | 3.57091244 |
| 83 | negative T cell selection (GO:0043383) | 3.56993213 |
| 84 | negative thymic T cell selection (GO:0045060) | 3.54851233 |
| 85 | succinate metabolic process (GO:0006105) | 3.54343923 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 3.53883951 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.53066639 |
| 88 | indolalkylamine metabolic process (GO:0006586) | 3.52186580 |
| 89 | bile acid and bile salt transport (GO:0015721) | 3.51515892 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.50479862 |
| 91 | ketone body metabolic process (GO:1902224) | 3.50335357 |
| 92 | valine metabolic process (GO:0006573) | 3.48746635 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 3.47138362 |
| 94 | tricarboxylic acid cycle (GO:0006099) | 3.42587420 |
| 95 | protein-cofactor linkage (GO:0018065) | 3.41953607 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41435447 |
| 97 | oxidative phosphorylation (GO:0006119) | 3.41145348 |
| 98 | vitamin D metabolic process (GO:0042359) | 3.40367256 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40027938 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.39717707 |
| 101 | drug metabolic process (GO:0017144) | 3.35566955 |
| 102 | branched-chain amino acid catabolic process (GO:0009083) | 3.34591241 |
| 103 | omega-hydroxylase P450 pathway (GO:0097267) | 3.33807980 |
| 104 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32669182 |
| 105 | fatty acid catabolic process (GO:0009062) | 3.32604395 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.32374930 |
| 107 | fatty acid oxidation (GO:0019395) | 3.28719807 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26091510 |
| 109 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.26071387 |
| 110 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.26071387 |
| 111 | NADH dehydrogenase complex assembly (GO:0010257) | 3.26071387 |
| 112 | drug catabolic process (GO:0042737) | 3.25107525 |
| 113 | urate metabolic process (GO:0046415) | 3.24493068 |
| 114 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.22733613 |
| 115 | cellular glucuronidation (GO:0052695) | 3.22575477 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.21628543 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.21628543 |
| 118 | lipid oxidation (GO:0034440) | 3.21624483 |
| 119 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.20327264 |
| 120 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.19740713 |
| 121 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.19740713 |
| 122 | dicarboxylic acid metabolic process (GO:0043648) | 3.18909032 |
| 123 | protein complex biogenesis (GO:0070271) | 3.18613285 |
| 124 | oxidative demethylation (GO:0070989) | 3.18062407 |
| 125 | cellular anion homeostasis (GO:0030002) | 3.17266113 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.15422729 |
| 127 | steroid catabolic process (GO:0006706) | 3.12950600 |
| 128 | branched-chain amino acid metabolic process (GO:0009081) | 3.10616156 |
| 129 | trivalent inorganic anion homeostasis (GO:0072506) | 3.05592925 |
| 130 | phosphate ion homeostasis (GO:0055062) | 3.05592925 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.01569793 |
| 132 | S-adenosylmethionine metabolic process (GO:0046500) | 2.94431727 |
| 133 | folic acid transport (GO:0015884) | 2.93144110 |
| 134 | heme transport (GO:0015886) | 2.88849657 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.87634685 |
| 136 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87634685 |
| 137 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.84300722 |
| 138 | primary alcohol catabolic process (GO:0034310) | 2.81979321 |
| 139 | regulation of humoral immune response (GO:0002920) | 2.81688586 |
| 140 | regulation of lipoprotein particle clearance (GO:0010984) | 2.79658860 |
| 141 | fibrinolysis (GO:0042730) | 2.79077844 |
| 142 | cellular response to interleukin-15 (GO:0071350) | 2.78606924 |
| 143 | ethanol metabolic process (GO:0006067) | 2.78420025 |
| 144 | drug transport (GO:0015893) | 2.77936925 |
| 145 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.76303519 |
| 146 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70691530 |
| 147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70451482 |
| 148 | cholesterol efflux (GO:0033344) | 2.68781965 |
| 149 | amino acid salvage (GO:0043102) | 2.67987555 |
| 150 | L-methionine salvage (GO:0071267) | 2.67987555 |
| 151 | L-methionine biosynthetic process (GO:0071265) | 2.67987555 |
| 152 | response to nitrosative stress (GO:0051409) | 2.67010931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.19231228 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14934662 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47251734 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.05935065 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75685383 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.47065796 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21162918 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.17720828 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67425616 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.46991040 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.95599525 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.74842128 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.61340489 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.57761115 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38775712 |
| 16 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26855080 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.21503854 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16469155 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16265195 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.09921650 |
| 21 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.92069264 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91595342 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89581419 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88760617 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85283025 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.78814467 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78176713 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.74183489 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.69712085 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.69091472 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66396713 |
| 32 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64797110 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.64714283 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61227734 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59267508 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59104323 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54831697 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54604794 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53074302 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53012722 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.52969353 |
| 42 | P300_27268052_Chip-Seq_Bcells_Human | 1.47798585 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.46165549 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.45627784 |
| 45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.45326279 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42702439 |
| 47 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40218295 |
| 48 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39852089 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37612862 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37349033 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37204509 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36572934 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.35954281 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35930071 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30109530 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29910700 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27953033 |
| 58 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27746438 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26119967 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24781129 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23988682 |
| 62 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23252656 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22559938 |
| 64 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22457703 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21915747 |
| 66 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.21068568 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20675032 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20279725 |
| 69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.19587182 |
| 70 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19441068 |
| 71 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18042127 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17529691 |
| 73 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17109330 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.14948674 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10829702 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10671358 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10013913 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.09509058 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09470790 |
| 80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09204152 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08843129 |
| 82 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.07698927 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06595554 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06070265 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05989658 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05413210 |
| 87 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04612965 |
| 88 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04260683 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03572993 |
| 90 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02816439 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01189568 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00064979 |
| 93 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00053719 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00025867 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99887660 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99762114 |
| 97 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99560554 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99517050 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 0.99340433 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99038551 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98860547 |
| 102 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98798509 |
| 103 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98758617 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97929487 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.97857225 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96745537 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96594569 |
| 108 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95556174 |
| 109 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95501375 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95329257 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95064179 |
| 112 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94992088 |
| 113 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94286494 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94245739 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94109759 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94099284 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93783086 |
| 118 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.93478638 |
| 119 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92030433 |
| 120 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91081201 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90157482 |
| 122 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89977690 |
| 123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89042576 |
| 124 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.88357787 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88304342 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88271946 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87729053 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85864704 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84968858 |
| 130 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84900264 |
| 131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83705479 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80631602 |
| 133 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.80450483 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79901690 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78602105 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77921545 |
| 137 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77388292 |
| 138 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.77156951 |
| 139 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.77045291 |
| 140 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76665284 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75488811 |
| 142 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.74696752 |
| 143 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.72922250 |
| 144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.72624367 |
| 145 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.72543892 |
| 146 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72316531 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70794713 |
| 148 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70436898 |
| 149 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.69645037 |
| 150 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69620419 |
| 151 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69353422 |
| 152 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68792694 |
| 153 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68723920 |
| 154 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.68680377 |
| 155 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.67594874 |
| 156 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.67354794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.82164195 |
| 2 | MP0005360_urolithiasis | 6.17572538 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.63631644 |
| 4 | MP0005365_abnormal_bile_salt | 5.60401827 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95438189 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.49470772 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.19158144 |
| 8 | MP0003195_calcinosis | 2.90990971 |
| 9 | MP0003252_abnormal_bile_duct | 2.85464280 |
| 10 | MP0009840_abnormal_foam_cell | 2.82782955 |
| 11 | MP0005332_abnormal_amino_acid | 2.69928082 |
| 12 | MP0005083_abnormal_biliary_tract | 2.55750391 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.34886135 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.19853895 |
| 15 | MP0009697_abnormal_copulation | 2.14652709 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.07498057 |
| 17 | MP0003646_muscle_fatigue | 2.04569147 |
| 18 | * MP0001764_abnormal_homeostasis | 1.99019133 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.95620773 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.95334509 |
| 21 | MP0003186_abnormal_redox_activity | 1.93375770 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.92154538 |
| 23 | MP0000609_abnormal_liver_physiology | 1.89400365 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.89138154 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.79774797 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.75033167 |
| 27 | MP0002723_abnormal_immune_serum | 1.67551535 |
| 28 | MP0004043_abnormal_pH_regulation | 1.67346172 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.56156335 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.53280189 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.51105322 |
| 32 | MP0003868_abnormal_feces_composition | 1.51098811 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.47027012 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.46764758 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.43158380 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.38530226 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.36897443 |
| 38 | MP0001819_abnormal_immune_cell | 1.36885854 |
| 39 | MP0002419_abnormal_innate_immunity | 1.35969868 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.34613842 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.34110948 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.33195430 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.30659932 |
| 44 | MP0001790_abnormal_immune_system | 1.30530388 |
| 45 | MP0005387_immune_system_phenotype | 1.30530388 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.26960948 |
| 47 | MP0003724_increased_susceptibility_to | 1.25748287 |
| 48 | MP0002822_catalepsy | 1.24246642 |
| 49 | MP0000716_abnormal_immune_system | 1.22511275 |
| 50 | MP0002736_abnormal_nociception_after | 1.22261672 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.19774385 |
| 52 | MP0005266_abnormal_metabolism | 1.18031764 |
| 53 | MP0002722_abnormal_immune_system | 1.15073192 |
| 54 | MP0000598_abnormal_liver_morphology | 1.14332880 |
| 55 | MP0002254_reproductive_system_inflammat | 1.14300493 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.14264043 |
| 57 | MP0002398_abnormal_bone_marrow | 1.13717369 |
| 58 | MP0003866_abnormal_defecation | 1.10856747 |
| 59 | MP0001661_extended_life_span | 1.09400466 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.09000500 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.07826344 |
| 62 | MP0008469_abnormal_protein_level | 1.07732290 |
| 63 | MP0001853_heart_inflammation | 1.06330065 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.06038875 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.04619252 |
| 66 | * MP0005376_homeostasis/metabolism_phenot | 1.04449845 |
| 67 | MP0003011_delayed_dark_adaptation | 1.04114113 |
| 68 | MP0000749_muscle_degeneration | 1.03215311 |
| 69 | MP0005330_cardiomyopathy | 1.02130662 |
| 70 | MP0005389_reproductive_system_phenotype | 0.99121614 |
| 71 | MP0008872_abnormal_physiological_respon | 0.97324487 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.96041736 |
| 73 | MP0009764_decreased_sensitivity_to | 0.95588896 |
| 74 | MP0005451_abnormal_body_composition | 0.95328615 |
| 75 | MP0002405_respiratory_system_inflammati | 0.94621713 |
| 76 | MP0004147_increased_porphyrin_level | 0.92754416 |
| 77 | MP0002429_abnormal_blood_cell | 0.92500685 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.92035226 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.91212543 |
| 80 | MP0002269_muscular_atrophy | 0.90936974 |
| 81 | MP0009763_increased_sensitivity_to | 0.89895474 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.88490082 |
| 83 | MP0004130_abnormal_muscle_cell | 0.84359652 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.83960350 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.83344646 |
| 86 | MP0009785_altered_susceptibility_to | 0.82383866 |
| 87 | MP0006054_spinal_hemorrhage | 0.81543944 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.81389917 |
| 89 | MP0001835_abnormal_antigen_presentation | 0.79934036 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.79272301 |
| 91 | MP0001542_abnormal_bone_strength | 0.78820348 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.78118067 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.77026105 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.76887088 |
| 95 | MP0005535_abnormal_body_temperature | 0.76875943 |
| 96 | MP0008995_early_reproductive_senescence | 0.73934466 |
| 97 | MP0002160_abnormal_reproductive_system | 0.73489669 |
| 98 | MP0005670_abnormal_white_adipose | 0.72498387 |
| 99 | MP0000604_amyloidosis | 0.72377815 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.71675786 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.71382519 |
| 102 | MP0005671_abnormal_response_to | 0.70776196 |
| 103 | MP0004142_abnormal_muscle_tone | 0.70768747 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.70236633 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.69583261 |
| 106 | MP0002132_abnormal_respiratory_system | 0.68013494 |
| 107 | MP0005647_abnormal_sex_gland | 0.67983795 |
| 108 | MP0004133_heterotaxia | 0.67839821 |
| 109 | MP0001968_abnormal_touch/_nociception | 0.67799089 |
| 110 | MP0001919_abnormal_reproductive_system | 0.67715630 |
| 111 | MP0000685_abnormal_immune_system | 0.66090511 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.65173633 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.64747111 |
| 114 | MP0008874_decreased_physiological_sensi | 0.63575744 |
| 115 | MP0005385_cardiovascular_system_phenoty | 0.62732869 |
| 116 | MP0001544_abnormal_cardiovascular_syste | 0.62732869 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.61937589 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.61099049 |
| 119 | MP0002127_abnormal_cardiovascular_syste | 0.59671021 |
| 120 | MP0001756_abnormal_urination | 0.58909608 |
| 121 | MP0003879_abnormal_hair_cell | 0.58244649 |
| 122 | MP0003436_decreased_susceptibility_to | 0.57117017 |
| 123 | MP0003718_maternal_effect | 0.55294695 |
| 124 | MP0005165_increased_susceptibility_to | 0.54718060 |
| 125 | MP0005334_abnormal_fat_pad | 0.53527457 |
| 126 | MP0000751_myopathy | 0.53314203 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.52110180 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.52110180 |
| 129 | MP0005448_abnormal_energy_balance | 0.51398081 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.51327710 |
| 131 | MP0008873_increased_physiological_sensi | 0.50746958 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.49694569 |
| 133 | MP0002971_abnormal_brown_adipose | 0.48992057 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.48769899 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.48008040 |
| 136 | MP0005025_abnormal_response_to | 0.47123113 |
| 137 | MP0003075_altered_response_to | 0.46082639 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46071114 |
| 139 | MP0002396_abnormal_hematopoietic_system | 0.44321017 |
| 140 | MP0006138_congestive_heart_failure | 0.44266957 |
| 141 | MP0000639_abnormal_adrenal_gland | 0.43666857 |
| 142 | MP0001800_abnormal_humoral_immune | 0.41811129 |
| 143 | MP0005166_decreased_susceptibility_to | 0.40733111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.72263413 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.26102033 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.17980790 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.00412182 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.70481717 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.59236689 |
| 7 | Hyperammonemia (HP:0001987) | 4.54814575 |
| 8 | Xanthomatosis (HP:0000991) | 4.50104406 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.23127520 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.21341571 |
| 11 | Hyperglycinemia (HP:0002154) | 4.15891795 |
| 12 | Ketosis (HP:0001946) | 4.04878752 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77605498 |
| 14 | Hyperglycinuria (HP:0003108) | 3.70322932 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66893652 |
| 16 | Osteomalacia (HP:0002749) | 3.65079849 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.63606370 |
| 18 | Cerebral edema (HP:0002181) | 3.60868634 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.56692273 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.56692273 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.56035639 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 3.54494758 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.54494758 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46800316 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.45787334 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43488816 |
| 27 | Hepatic necrosis (HP:0002605) | 3.43076728 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.37644331 |
| 29 | Joint hemorrhage (HP:0005261) | 3.36747075 |
| 30 | Vascular calcification (HP:0004934) | 3.35760000 |
| 31 | Stomatitis (HP:0010280) | 3.34799974 |
| 32 | Hyperbilirubinemia (HP:0002904) | 3.30868042 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29038046 |
| 34 | Lethargy (HP:0001254) | 3.28813704 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.27272236 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25058834 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.23759673 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.22219013 |
| 39 | Complement deficiency (HP:0004431) | 3.17417829 |
| 40 | Ketoacidosis (HP:0001993) | 3.12392686 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.08934190 |
| 42 | Acute encephalopathy (HP:0006846) | 3.07676711 |
| 43 | Fat malabsorption (HP:0002630) | 3.06049076 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04582916 |
| 45 | * Metabolic acidosis (HP:0001942) | 3.03624422 |
| 46 | Hyperalaninemia (HP:0003348) | 3.02253961 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.02253961 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 3.02253961 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 3.02012026 |
| 50 | Generalized aminoaciduria (HP:0002909) | 3.01925668 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.97003875 |
| 52 | Hepatocellular necrosis (HP:0001404) | 2.92723122 |
| 53 | Gout (HP:0001997) | 2.89169453 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88257360 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81359075 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80480918 |
| 57 | Abnormal biliary tract physiology (HP:0012439) | 2.80437382 |
| 58 | Bile duct proliferation (HP:0001408) | 2.80437382 |
| 59 | Lactic acidosis (HP:0003128) | 2.76968805 |
| 60 | Epidermoid cyst (HP:0200040) | 2.75561602 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.74555106 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.70998169 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.68312834 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65208605 |
| 65 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.62699542 |
| 66 | Gingival bleeding (HP:0000225) | 2.58124394 |
| 67 | Increased CSF lactate (HP:0002490) | 2.56572590 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.56372931 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 2.55262963 |
| 70 | Nausea (HP:0002018) | 2.54469996 |
| 71 | Elevated alkaline phosphatase (HP:0003155) | 2.54383209 |
| 72 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.52197918 |
| 73 | * Vomiting (HP:0002013) | 2.51879380 |
| 74 | Pustule (HP:0200039) | 2.51371316 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.49252899 |
| 76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.49112397 |
| 77 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.49112397 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.47202534 |
| 79 | Spontaneous abortion (HP:0005268) | 2.46142008 |
| 80 | Myoglobinuria (HP:0002913) | 2.44243500 |
| 81 | Abnormal urine phosphate concentration (HP:0012599) | 2.42603217 |
| 82 | Steatorrhea (HP:0002570) | 2.42427868 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39979650 |
| 84 | Cholelithiasis (HP:0001081) | 2.38264464 |
| 85 | Increased muscle lipid content (HP:0009058) | 2.35772695 |
| 86 | Neonatal onset (HP:0003623) | 2.35753466 |
| 87 | Palpitations (HP:0001962) | 2.34601697 |
| 88 | Myositis (HP:0100614) | 2.34503274 |
| 89 | Increased serum lactate (HP:0002151) | 2.29611718 |
| 90 | Rhabdomyolysis (HP:0003201) | 2.28828126 |
| 91 | Abnormality of complement system (HP:0005339) | 2.28243062 |
| 92 | Abnormality of renal resorption (HP:0011038) | 2.27641313 |
| 93 | Pulmonary embolism (HP:0002204) | 2.27172895 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.26436316 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.26068499 |
| 96 | Anorexia (HP:0002039) | 2.25678143 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.24856039 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.24491909 |
| 99 | Late onset (HP:0003584) | 2.24107934 |
| 100 | Chronic otitis media (HP:0000389) | 2.22143925 |
| 101 | Methylmalonic aciduria (HP:0012120) | 2.16465317 |
| 102 | Type I transferrin isoform profile (HP:0003642) | 2.14567190 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14354077 |
| 104 | Cholecystitis (HP:0001082) | 2.13735801 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.13735801 |
| 106 | Abnormality of glycolysis (HP:0004366) | 2.07762895 |
| 107 | Increased serum pyruvate (HP:0003542) | 2.07762895 |
| 108 | Acute hepatic failure (HP:0006554) | 2.06733495 |
| 109 | Recurrent fungal infections (HP:0002841) | 2.06377496 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 2.05603585 |
| 111 | Glycosuria (HP:0003076) | 2.05603585 |
| 112 | IgG deficiency (HP:0004315) | 2.04754178 |
| 113 | Progressive macrocephaly (HP:0004481) | 2.04293878 |
| 114 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02538867 |
| 115 | Cerebral palsy (HP:0100021) | 2.01713881 |
| 116 | Agammaglobulinemia (HP:0004432) | 2.01692093 |
| 117 | Rickets (HP:0002748) | 2.00922911 |
| 118 | CNS demyelination (HP:0007305) | 1.98786667 |
| 119 | Epistaxis (HP:0000421) | 1.98448773 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98080335 |
| 121 | Spastic diplegia (HP:0001264) | 1.96944740 |
| 122 | Sensorimotor neuropathy (HP:0007141) | 1.96472199 |
| 123 | Hepatocellular carcinoma (HP:0001402) | 1.96449628 |
| 124 | Renal cortical cysts (HP:0000803) | 1.96073861 |
| 125 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95897451 |
| 126 | Opisthotonus (HP:0002179) | 1.95738586 |
| 127 | Brushfield spots (HP:0001088) | 1.95519566 |
| 128 | Acanthocytosis (HP:0001927) | 1.94886236 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.91121621 |
| 130 | Hypophosphatemia (HP:0002148) | 1.88341339 |
| 131 | Status epilepticus (HP:0002133) | 1.88218795 |
| 132 | Joint swelling (HP:0001386) | 1.87917224 |
| 133 | Pancreatitis (HP:0001733) | 1.87759923 |
| 134 | Thrombophlebitis (HP:0004418) | 1.87113219 |
| 135 | Abnormality of the prostate (HP:0008775) | 1.87022585 |
| 136 | Seborrheic dermatitis (HP:0001051) | 1.86868333 |
| 137 | Malnutrition (HP:0004395) | 1.86139205 |
| 138 | Type 2 muscle fiber atrophy (HP:0003554) | 1.85269007 |
| 139 | Optic disc pallor (HP:0000543) | 1.85025212 |
| 140 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84172198 |
| 141 | Nonprogressive disorder (HP:0003680) | 1.83927896 |
| 142 | Gastrointestinal infarctions (HP:0005244) | 1.82893849 |
| 143 | Irritability (HP:0000737) | 1.82723659 |
| 144 | Hypochromic microcytic anemia (HP:0004840) | 1.82667889 |
| 145 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82537268 |
| 146 | Abnormality of T cells (HP:0002843) | 1.80603436 |
| 147 | Emotional lability (HP:0000712) | 1.79857317 |
| 148 | Glomerulonephritis (HP:0000099) | 1.78907731 |
| 149 | Petechiae (HP:0000967) | 1.78353921 |
| 150 | Purpura (HP:0000979) | 1.78180290 |
| 151 | Constricted visual fields (HP:0001133) | 1.76311177 |
| 152 | Recurrent bacterial skin infections (HP:0005406) | 1.72526630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.39737685 |
| 2 | PASK | 3.45325053 |
| 3 | MAP3K12 | 3.41621938 |
| 4 | MYLK | 2.69459688 |
| 5 | ERN1 | 2.65699477 |
| 6 | TESK2 | 2.58034171 |
| 7 | KDR | 2.57098961 |
| 8 | DAPK1 | 2.48233013 |
| 9 | MAP4K2 | 2.47759322 |
| 10 | TAOK3 | 2.42255175 |
| 11 | DAPK2 | 2.21357807 |
| 12 | CASK | 2.19354699 |
| 13 | NEK1 | 2.11262397 |
| 14 | FLT3 | 2.10911503 |
| 15 | TLK1 | 2.08462794 |
| 16 | MAP4K1 | 2.07216199 |
| 17 | CDK19 | 2.04408770 |
| 18 | MAP3K11 | 2.02900390 |
| 19 | MUSK | 1.98639861 |
| 20 | FGFR4 | 1.94320091 |
| 21 | ACVR1B | 1.89660605 |
| 22 | OBSCN | 1.77311997 |
| 23 | CCNB1 | 1.75116965 |
| 24 | NME2 | 1.66086668 |
| 25 | PDK3 | 1.65538634 |
| 26 | PDK4 | 1.65538634 |
| 27 | ITK | 1.62177062 |
| 28 | NME1 | 1.55349775 |
| 29 | MAP2K4 | 1.48301798 |
| 30 | RIPK4 | 1.46732706 |
| 31 | TXK | 1.45342871 |
| 32 | MAPKAPK3 | 1.45140182 |
| 33 | TYK2 | 1.44800615 |
| 34 | TIE1 | 1.44502223 |
| 35 | PINK1 | 1.41198549 |
| 36 | TGFBR1 | 1.39583628 |
| 37 | STK16 | 1.39397528 |
| 38 | CAMKK1 | 1.38346568 |
| 39 | EIF2AK1 | 1.34878809 |
| 40 | AKT3 | 1.32570334 |
| 41 | SIK2 | 1.31552419 |
| 42 | TBK1 | 1.31089429 |
| 43 | NUAK1 | 1.28994305 |
| 44 | MAP2K3 | 1.27679255 |
| 45 | MAP2K6 | 1.27082260 |
| 46 | FES | 1.26117868 |
| 47 | SIK3 | 1.26038067 |
| 48 | MAPK11 | 1.25354218 |
| 49 | MAPK12 | 1.19273431 |
| 50 | GRK1 | 1.16764104 |
| 51 | TAOK2 | 1.15980387 |
| 52 | LCK | 1.15125346 |
| 53 | PRKCQ | 1.11927447 |
| 54 | NTRK2 | 1.08443735 |
| 55 | PIK3CA | 1.04932693 |
| 56 | PIM2 | 1.04396827 |
| 57 | VRK2 | 1.03727265 |
| 58 | PKN2 | 1.03667120 |
| 59 | ZAP70 | 1.01364005 |
| 60 | SIK1 | 1.00800177 |
| 61 | DAPK3 | 0.99705442 |
| 62 | EIF2AK3 | 0.99319835 |
| 63 | MAPK4 | 0.98304383 |
| 64 | GRK7 | 0.97828849 |
| 65 | PDK2 | 0.97505720 |
| 66 | BTK | 0.97024062 |
| 67 | BUB1 | 0.96626026 |
| 68 | FRK | 0.94484032 |
| 69 | MAP3K7 | 0.94286104 |
| 70 | GRK6 | 0.93851133 |
| 71 | MAP3K14 | 0.93530010 |
| 72 | MAP2K7 | 0.92622207 |
| 73 | MAP3K13 | 0.91991433 |
| 74 | KIT | 0.91496925 |
| 75 | IKBKE | 0.89141135 |
| 76 | CAMKK2 | 0.86329380 |
| 77 | SGK223 | 0.83291893 |
| 78 | SGK494 | 0.83291893 |
| 79 | MARK3 | 0.82128795 |
| 80 | TSSK6 | 0.79750795 |
| 81 | CDK9 | 0.79246230 |
| 82 | FGR | 0.76452829 |
| 83 | ADRBK1 | 0.75028901 |
| 84 | PIK3CG | 0.74779383 |
| 85 | TEC | 0.73015883 |
| 86 | DYRK2 | 0.72697848 |
| 87 | SYK | 0.72609540 |
| 88 | TGFBR2 | 0.71249045 |
| 89 | CAMK1 | 0.70281865 |
| 90 | STK24 | 0.67172402 |
| 91 | MST4 | 0.64834082 |
| 92 | MAP3K3 | 0.64064725 |
| 93 | CAMK4 | 0.64006309 |
| 94 | EPHA4 | 0.63893759 |
| 95 | MAPK7 | 0.63773061 |
| 96 | VRK1 | 0.63695201 |
| 97 | MATK | 0.63690430 |
| 98 | CDK8 | 0.62523437 |
| 99 | MAP3K5 | 0.62239861 |
| 100 | JAK1 | 0.62038036 |
| 101 | MAPK13 | 0.61759230 |
| 102 | ADRBK2 | 0.59905343 |
| 103 | PRKD2 | 0.59567269 |
| 104 | BMPR1B | 0.59151746 |
| 105 | ABL2 | 0.59054413 |
| 106 | HCK | 0.55719237 |
| 107 | PIM1 | 0.55468988 |
| 108 | TNK2 | 0.53493896 |
| 109 | STK11 | 0.53061714 |
| 110 | INSRR | 0.52273654 |
| 111 | JAK2 | 0.51735960 |
| 112 | CSF1R | 0.51041538 |
| 113 | GRK5 | 0.50897211 |
| 114 | WEE1 | 0.50884298 |
| 115 | NLK | 0.50077726 |
| 116 | NEK9 | 0.47763278 |
| 117 | SGK2 | 0.44409428 |
| 118 | IRAK4 | 0.42540964 |
| 119 | CSK | 0.42187731 |
| 120 | MAP3K4 | 0.42171806 |
| 121 | BLK | 0.41844315 |
| 122 | MAPKAPK5 | 0.41314425 |
| 123 | ERBB4 | 0.40942899 |
| 124 | FGFR2 | 0.39564928 |
| 125 | PRKCZ | 0.38757703 |
| 126 | PRKCG | 0.38538814 |
| 127 | BMPR2 | 0.38188686 |
| 128 | IRAK3 | 0.38080192 |
| 129 | IGF1R | 0.37705572 |
| 130 | EPHA3 | 0.37553091 |
| 131 | MAPK15 | 0.37495048 |
| 132 | PRKAA2 | 0.37017770 |
| 133 | LYN | 0.36955601 |
| 134 | CAMK2G | 0.36151242 |
| 135 | CSNK1A1 | 0.34948777 |
| 136 | IKBKB | 0.33710766 |
| 137 | ZAK | 0.33496263 |
| 138 | CHUK | 0.33477836 |
| 139 | CSNK2A1 | 0.32405085 |
| 140 | PRKACA | 0.31256119 |
| 141 | FYN | 0.31159264 |
| 142 | MAP2K2 | 0.30981358 |
| 143 | PRKACG | 0.30976191 |
| 144 | JAK3 | 0.30374030 |
| 145 | MAP3K1 | 0.30076393 |
| 146 | MST1R | 0.29042701 |
| 147 | AKT2 | 0.28163324 |
| 148 | PDK1 | 0.27833049 |
| 149 | RPS6KB2 | 0.26665097 |
| 150 | PRKCD | 0.25345939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.07916236 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.89819409 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.95569897 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85246443 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83662222 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.78102613 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.65371354 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54612460 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44381677 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34215420 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27215172 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26274696 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.21074233 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19470860 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19311372 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07324440 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06980056 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.01556973 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.99665953 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87427525 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84952998 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.83277254 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.80473677 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.79752758 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79255028 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.72091311 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71026956 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67306521 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66674972 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64989732 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64504468 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61411393 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59428166 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57074188 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55968148 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46923858 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38986266 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34273322 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33560696 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33516071 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29379388 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27417718 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27114402 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24544927 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23869317 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23750062 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22265213 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21740981 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17193968 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15332760 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15030645 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14213153 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11008041 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08052028 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.07224357 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05393341 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 1.01188362 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01003072 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.99304515 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.98114219 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94730966 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94459174 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93849770 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92394641 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92206250 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91209727 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90222722 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84647114 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82592439 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82363962 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.81647670 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74979721 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74149369 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70026779 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69918013 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69028697 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66137059 |
| 78 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65677945 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63743694 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.63625440 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60213638 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53030623 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52163094 |
| 84 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.50597238 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49425674 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.49308912 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48754949 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48025581 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46313459 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45847557 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44281094 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39678732 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39233113 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37191792 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36801799 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.36439886 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34539010 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33860935 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.29621804 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29602383 |
| 101 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29056720 |
| 102 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28151711 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25555441 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.24753132 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.18833196 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.16803285 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.14369154 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14127453 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11700323 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.11323215 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.10160603 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08438328 |
| 113 | Base excision repair_Homo sapiens_hsa03410 | 0.05790104 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.03666516 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.02900572 |
| 116 | Protein export_Homo sapiens_hsa03060 | -0.1151205 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0986116 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.0971021 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0552397 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0508222 |
| 121 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.0462886 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0310874 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0245474 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0178192 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0078162 |

